{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T09:29:25Z","timestamp":1720258165320},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Defence Research & Development Organization (DRDO), New Delhi, India"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chemical Neuroanatomy"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jchemneu.2015.12.007","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T10:58:53Z","timestamp":1450522733000},"page":"8-15","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Fluorination of an antiepileptic drug: A self supporting transporter by oxygen enrichment mechanism"],"prefix":"10.1016","volume":"72","author":[{"given":"V.","family":"Natchimuthu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Amoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchemneu.2015.12.007_bib0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nurt.2009.01.018","article-title":"Nanotechnology for the delivery of drugs to the brain for epilepsy","volume":"6","author":"Bennewitz","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0169-409X(90)90016-L","article-title":"Parenteral emulsions for drug delivery","volume":"5","author":"Collins-Gold","year":"1990","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jfluchem.2004.09.033","article-title":"Fluorine chemistry at the millennium","volume":"126","author":"Dolbier","year":"2005","journal-title":"J. Fluorine Chem."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002329900434","volume":"165","author":"Fischer","year":"1998","journal-title":"J. Membr. Biol."},{"issue":"3","key":"10.1016\/j.jchemneu.2015.12.007_bib0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1528-1167.2011.03365.x","article-title":"The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy","volume":"53","author":"Gunthorpe","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1007001923498","volume":"20","author":"Habgood","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1166\/sam.2009.1009","article-title":"Controlled release of phenytoin from nanostructured TiO2 reservoirs","volume":"1","author":"Heredia-Cervera","year":"2009","journal-title":"Sci Adv. Mater."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0040","first-page":"628","article-title":"Design, synthesis and anticonvulsant activity of some new 5,7-dibromoisatin semicarbazone derivatives","volume":"12","author":"Kumar","year":"2013","journal-title":"EXCLI J."},{"issue":"2","key":"10.1016\/j.jchemneu.2015.12.007_bib0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneumeth.2012.10.018","article-title":"Advantages and limitations of brain imaging methods in the research of absence epilepsy in humans and animal models","volume":"212","author":"Lenkov","year":"2013","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv. Rev."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0055","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jbm.a.30842","article-title":"Molecular vibrational analysis and MAS-NMR spectroscopy study of epilepsy drugs encapsulated in TiO2\u2013sol\u2013gel reservoirs","volume":"78A","author":"Lopez","year":"2006","journal-title":"J Biomed. Mater. Res."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0060","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.matchar.2006.11.006","article-title":"Characterization of sodium phenytoin co-gelled with Titania for a controlled drug-release system","volume":"58","author":"Lopez","year":"2007","journal-title":"Mater. Charact."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0065","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1007\/s10853-009-3745-8","article-title":"Kinetic study of controlled release of VPA and DPH antiepileptic drugs using biocompatible nanostructured sol\u2013gel TiO2","volume":"44","author":"Lopez","year":"2009","journal-title":"J. Mater. Sci."},{"issue":"47","key":"10.1016\/j.jchemneu.2015.12.007_bib0070","doi-asserted-by":"crossref","first-page":"20022","DOI":"10.1021\/jp105356q","article-title":"Role of hydrolysis degree in the drug\u2013matrix interactions of nanosized sol\u2013gel titania reservoirs for epilepsy treatment","volume":"114","author":"Lopez","year":"2010","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0075","doi-asserted-by":"crossref","unstructured":"Lopez, Tessy, Anna, Kozina, Emma, Ortiz-Islas, Karla, A., Espinoza, Richard, Gonzalez, 2011. In-situ Release of Antiepileptic Drugs from Nanostructured Reservoirs, Underlying Mechanisms of Epilepsy, Prof. Fatima Shad Kaneez (Ed.), ISBN: 978-953-307-765-9.","DOI":"10.5772\/18944"},{"issue":"3","key":"10.1016\/j.jchemneu.2015.12.007_bib0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neures.2009.03.010","article-title":"N-(anilinomethyl)-p-isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model","volume":"64","author":"Luszczki","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/10611860601141150","article-title":"1-O-alkylglycerol stabilized carbamazepine intravenous o\/w nanoemulsions for drug targeting in mice","volume":"15","author":"Madhusudhan","year":"2007","journal-title":"J. Drug Target"},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jfluchem.2006.01.009","article-title":"Synthesis and anticonvulsant activity of new fluorinated N-phenyl- and N-benzyl-2-azaspiro[4. 4]nonane- and [4.5]decane-1,3-dione derivatives: part III","volume":"127","author":"Obniska","year":"2006","journal-title":"J. Fluorine Chem."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0095","doi-asserted-by":"crossref","unstructured":"Ooi, S.-Y.; Ball, S. Prescriber, 2007, 18,48.","DOI":"10.1002\/psb.38"},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0100","doi-asserted-by":"crossref","unstructured":"Ooi, S.-Y.; Ball, S. Prescriber 2009, 20, 15.","DOI":"10.1002\/psb.538"},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0105","series-title":"Brain Drug Targeting: The Future of Brain Drug Development","author":"Pardridge","year":"2001"},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0110","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(02)01054-1","article-title":"Drug and gene delivery to the brain: the vascular route","volume":"36","author":"Pardridge","year":"2002","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.jchemneu.2015.12.007_bib0115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1039\/B610213C","article-title":"Fluorine in medicinal chemistry","volume":"37","author":"Purser","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0120","first-page":"97","article-title":"Fluorofelbamate, neurotherapeutics","volume":"4","author":"Roecklein","year":"2007","journal-title":"J. Am. Soc. Exp. NeuroTher."},{"issue":"5","key":"10.1016\/j.jchemneu.2015.12.007_bib0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5698\/1535-7511-12.5.199","article-title":"Targeting anti-epileptic drug therapy without collateral damage: nanocarrier-based drug delivery","volume":"12","author":"Rossi","year":"2012","journal-title":"Epilepsy Curr."},{"issue":"2","key":"10.1016\/j.jchemneu.2015.12.007_bib0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0891-0618(91)90035-B","article-title":"Mapping of benzodiazepine-like immunoreactivity in the rat brain as revealed by a monoclonal antibody to benzodiazepines","volume":"4","author":"Sanchez","year":"1991","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0135","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bmc.2003.12.011","volume":"12","author":"Schenck","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-5173(97)00135-X","article-title":"Liposomes in drug delivery: progress and limitations","volume":"154","author":"Sharma","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(00)00055-7","volume":"42","author":"Shoichet","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.jchemneu.2015.12.007_bib0150","first-page":"790","volume":"43","author":"Siddiqui","year":"2006","journal-title":"Indian Drugs"},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-1139(01)00375-X","article-title":"Fluorine substituent effects (on bioactivity)","volume":"109","author":"Smart","year":"2001","journal-title":"J. Fluorine Chem."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jfluchem.2004.10.041","article-title":"Synthesis and bioactivity of 2-cyanoacrylates containing a trifluoromethylphenyl moiety","author":"Song","year":"2005","journal-title":"J. Fluorine Chem."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0920-1211(01)00330-8","article-title":"The intracerebral administration of phenytoin using controlled-release polymers reduces experimental seizures in rats","volume":"48","author":"Tamargo","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jchemneu.2015.12.007_bib0170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1166\/jnsne.2013.1088","article-title":"Targeted delivery of 4-aminopyridine into the rat brain by minicontainers from carbon-nanodiamonds composite","volume":"2","author":"Volnova","year":"2013","journal-title":"J. Neuroeng."},{"issue":"Suppl. 7","key":"10.1016\/j.jchemneu.2015.12.007_bib0175","first-page":"162","article-title":"Neuroprotective effects of the anticonvulsant, fluorofelbamate","volume":"41","author":"Wallis","year":"2000","journal-title":"Epilepsia"}],"container-title":["Journal of Chemical Neuroanatomy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891061815300272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891061815300272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T19:12:46Z","timestamp":1567451566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891061815300272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":35,"alternative-id":["S0891061815300272"],"URL":"https:\/\/doi.org\/10.1016\/j.jchemneu.2015.12.007","relation":{},"ISSN":["0891-0618"],"issn-type":[{"value":"0891-0618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorination of an antiepileptic drug: A self supporting transporter by oxygen enrichment mechanism","name":"articletitle","label":"Article Title"},{"value":"Journal of Chemical Neuroanatomy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchemneu.2015.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}